The opportunity cost of negative screening in socially responsible investing

P. J. Trinks, B. Scholtens

Research output: Contribution to journalArticlepeer-review

104 Citations (Scopus)
3 Downloads (Pure)

Abstract

This paper investigates the impact of negative screening on the investment universe as well as on financial performance. We come up with a novel identification process and as such depart from mainstream socially responsible investing literature by concentrating on individual firms’ conduct and by studying a much wider range of issues. Firstly, we study the size and financial performance of fourteen potentially controversial issues: abortion, adult entertainment, alcohol, animal testing, contraceptives, controversial weapons, fur, gambling, genetic engineering, meat, nuclear power, pork, (embryonic) stem cells, and tobacco. We investigate an international sample of more than 1,600 stocks for more than twenty years. We then analyze the impact of applying negative screens to a market portfolio. Our findings suggest that the choice for negative screening strategies does matter for the size of the investment universe as well as for risk-adjusted return performance. Investing in controversial stocks in many cases results in additional risk-adjusted returns, whereas excluding them may reduce financial performance. These findings suggest that there are opportunity costs to negative screening.
Original languageEnglish
Pages (from-to)193-208
Number of pages16
JournalJournal of Business Ethics
Volume140
Issue number2
Early online date15 May 2015
DOIs
Publication statusPublished - 27 Jan 2017

Keywords

  • Controversial investments
  • Market capitalization
  • Responsible investing
  • Risk-adjusted returns
  • Screening

Fingerprint

Dive into the research topics of 'The opportunity cost of negative screening in socially responsible investing'. Together they form a unique fingerprint.

Cite this